Clinical & Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, UK.
Nat Med. 2012 Jan 29;18(2):274-80. doi: 10.1038/nm.2612.
Protective immunity against influenza virus infection is mediated by neutralizing antibodies, but the precise role of T cells in human influenza immunity is uncertain. We conducted influenza infection studies in healthy volunteers with no detectable antibodies to the challenge viruses H3N2 or H1N1. We mapped T cell responses to influenza before and during infection. We found a large increase in influenza-specific T cell responses by day 7, when virus was completely cleared from nasal samples and serum antibodies were still undetectable. Preexisting CD4+, but not CD8+, T cells responding to influenza internal proteins were associated with lower virus shedding and less severe illness. These CD4+ cells also responded to pandemic H1N1 (A/CA/07/2009) peptides and showed evidence of cytotoxic activity. These cells are an important statistical correlate of homotypic and heterotypic response and may limit severity of influenza infection by new strains in the absence of specific antibody responses. Our results provide information that may aid the design of future vaccines against emerging influenza strains.
针对流感病毒感染的保护性免疫是由中和抗体介导的,但 T 细胞在人类流感免疫中的确切作用尚不确定。我们在没有检测到针对挑战病毒 H3N2 或 H1N1 的抗体的健康志愿者中进行了流感感染研究。我们在感染前后对 T 细胞反应进行了定位。我们发现,流感特异性 T 细胞反应在第 7 天迅速增加,此时病毒已从鼻样本中完全清除,血清抗体仍无法检测到。针对流感内部蛋白的预先存在的 CD4+,而不是 CD8+,T 细胞与较低的病毒脱落和较轻的疾病相关。这些 CD4+细胞也对大流行性 H1N1(A/CA/07/2009)肽产生反应,并显示出细胞毒性活性的证据。这些细胞是同型和异型反应的重要统计学相关因素,并且在没有特异性抗体反应的情况下,可能通过新的菌株限制流感感染的严重程度。我们的研究结果提供了可能有助于针对新出现的流感株设计未来疫苗的信息。